ArticleJournal of clinical medicine2020

Enhanced Antifibrinolytic Efficacy of a Plasmin-Specific Kunitz-Inhibitor (60-Residue Y11T/L17R with C-Terminal IEK) of Human Tissue Factor Pathway Inhibitor Type-2 Domain1.

Kanagasabai Vadivel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.